Our Guidance on the multi-disciplinary approach required to identify, manage, prevent and treat mental health patients at risk of or with AKI has been revised for 2018 and endorsed by the College of Mental Health Pharmacy Guidance for mental health professionals on the management of acute kidney injury
Read MoreLatest news
Here is a round-up of the latest news from Think Kidneys and our partners interested in the prevention of avoidable acute kidney injury.
If you have a news story relating to acute kidney injury you would like to share, get in touch.
CPPE Optimise programme – Biochemistry – focus on acute kidney injury
Think Kidneys have proudly been involved in developing some resources for pharmacists by supporting the CPPE Optimise Programme. The purpose of the CPPE Optimise programme Biochemistry – focus on acute kidney injury is to provide pharmacy professionals with a greater understanding of the biochemical changes that occur during acute kidney injury and encourage them to reflect on how they can explain those changes to patients. It…
Read MoreTackling Acute Kidney Injury: First results
The first results from the Tackling AKI study were presented in the ‘late breaking clinical trials’ poster session at the American Society of Nephrology conference in New Orleans, USA. Tackling AKI was a pragmatic clinical trial, funded by the Health Foundation, which tested the effectiveness of a complex intervention (AKI e-alerts, AKI care bundle and tailored education programme) across five UK hospitals. The study used a…
Read MoreChanges in kidney function and serum potassium during ACEI/ARB/diuretic treatment in primary care
A position statement from Think Kidneys, the Renal Association, and the British Society for Heart Failure We have revised our joint position statement, which can be downloaded here
Read More